Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss : Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
sudden sensorineural hearing loss: - idiopathic in most cases - 5-20/100,000 new cases annually in the U.S - no establishes pathogenesis - treated with oral steroids in most cases - ~50% improvement in hearing levels - bed rest - acceptable treatment, not well investigated.
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2006 |
|---|---|
| Erschienen: |
2006 |
| Enthalten in: |
ClinicalTrials.gov - (2006) vom: 27. Dez. Zur Gesamtaufnahme - year:2006 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: December 27, 2006, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021 |
|---|
| Study ID: |
NCT00416143 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG000356743 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG000356743 | ||
| 003 | DE-627 | ||
| 005 | 20230425201610.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210408s2006 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG000356743 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT00416143 | ||
| 035 | |a (UBBS_Klinische_Studien)SHEBA-06-4065-EC-CTIL | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss |b Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss |
| 264 | 1 | |c 2006 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: December 27, 2006, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021 | ||
| 520 | |a sudden sensorineural hearing loss: - idiopathic in most cases - 5-20/100,000 new cases annually in the U.S - no establishes pathogenesis - treated with oral steroids in most cases - ~50% improvement in hearing levels - bed rest - acceptable treatment, not well investigated | ||
| 650 | 2 | |a Hearing Loss | |
| 650 | 2 | |a Deafness | |
| 650 | 2 | |a Hearing Loss, Sensorineural | |
| 650 | 2 | |a Hearing Loss, Sudden | |
| 650 | 4 | |a Medical Condition: Sudden Loss of Hearing | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Recruitment Status: Unknown status | |
| 650 | 4 | |a Phase: Phase 2/Phase 3 | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2006) vom: 27. Dez. |
| 773 | 1 | 8 | |g year:2006 |g day:27 |g month:12 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT00416143 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2006 |b 27 |c 12 | ||